1.28
Schlusskurs vom Vortag:
$1.23
Offen:
$1.2
24-Stunden-Volumen:
8.72M
Relative Volume:
0.84
Marktkapitalisierung:
$815.25M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.00
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+1.59%
1M Leistung:
-15.23%
6M Leistung:
-57.19%
1J Leistung:
-72.65%
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
GERN
Geron Corp
|
1.28 | 802.52M | 29.48M | -201.19M | -216.50M | -0.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-10 | Fortgesetzt | Goldman | Sell |
2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2024-04-29 | Eingeleitet | TD Cowen | Buy |
2024-03-15 | Bestätigt | Needham | Buy |
2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
2023-03-28 | Eingeleitet | Goldman | Neutral |
2022-10-28 | Eingeleitet | Wedbush | Outperform |
2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
2020-08-03 | Eingeleitet | Stifel | Buy |
2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-04-09 | Hochstufung | Needham | Hold → Buy |
2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
2016-09-13 | Bestätigt | FBR & Co. | Outperform |
2016-09-13 | Bestätigt | FBR Capital | Outperform |
2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
2013-12-10 | Bestätigt | MLV & Co | Buy |
2013-12-10 | Hochstufung | Needham | Hold → Buy |
2013-11-08 | Bestätigt | MLV & Co | Buy |
2013-10-16 | Eingeleitet | MLV & Co | Buy |
2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com
Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st
Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com
Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest
Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan
Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser
What makes Geron Corporation stock price move sharplyTriple Return With Stability - Newser
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World
Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron resumed with a Sell at Goldman Sachs - TipRanks
Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating - TipRanks
Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales - Investing.com
Geron Corp (GERN) Stock: A Year of Highs and Lows - investchronicle.com
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN
13 Stocks Under $5 With High Upside Potential - Insider Monkey
DSS switches auditors to HTL; no disputes with Grassi reported | GERN SEC FilingForm 4 - Stock Titan
Geron Corporation(NasdaqGS: GERN) dropped from Russell 2500 Value Index - MarketScreener
Geron Corporation(NasdaqGS: GERN) dropped from Russell Small Cap Comp Value Index - MarketScreener
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Expands Team with 16 New Hires, Awards Over $1.6M in Stock Options and RSUs - Stock Titan
With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns - Yahoo Finance
Geron: A Tough First Year For Rytelo, But Not Yet Time To Sell (Downgrade) (NASDAQ:GERN) - Seeking Alpha
Favourable Signals For Geron: Numerous Insiders Acquired Stock - simplywall.st
Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges - Investing.com
Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges By Investing.com - Investing.com Canada
Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com
Class Action Filed Against Geron Corporation (GERN)May 12, 2025 Deadline to JoinContact The Gross Law Firm - mx.advfn.com
Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN) - Seeking Alpha
Is Geron Corporation Stock a Bargain Now? - StocksToTrade
Nuveen Asset Management LLC Purchases 14,657 Shares of Geron Co. (NASDAQ:GERN) - Defense World
Geron showcases RYTELO benefits at oncology meetings By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles By Investing.com - Investing.com South Africa
Geron showcases RYTELO benefits at oncology meetings - Investing.com
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Yahoo Finance
Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles - Investing.com
Geron Corp stockholders approve equity plan amendments By Investing.com - Investing.com India
Geron Corp stockholders approve equity plan amendments - Investing.com
BNP Paribas Financial Markets Decreases Stock Holdings in Geron Co. (NASDAQ:GERN) - Defense World
25,148 Shares in Geron Co. (NASDAQ:GERN) Purchased by Lazard Asset Management LLC - Defense World
Geron Co. (NASDAQ:GERN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Bank of America Corp DE Boosts Stock Position in Geron Co. (NASDAQ:GERN) - Defense World
Ameriprise Financial Inc. Buys 247,018 Shares of Geron Co. (NASDAQ:GERN) - Defense World
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GERN Stock News - GuruFocus
Geron Grants $522K Worth of Stock Options and RSUs: New Employee Compensation Details Revealed - Stock Titan
Stifel Financial Corp Increases Position in Geron Co. (NASDAQ:GERN) - Defense World
Geron Corp Stock (GERN): Demand Recovery on the Rise - Value The Markets
Northern Trust Corp Has $19.76 Million Stake in Geron Co. (NASDAQ:GERN) - Defense World
Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now - Insider Monkey
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):